Dicerna Pharmaceuticals Competitors and Similar CompaniesClear all
Dicerna Pharmaceuticals's competitors and similar companies include Morphogenesis and Abdera Therapeutics.
 Dicerna Pharmaceuticals Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases. |  Abdera Therapeutics Abdera Therapeutics is a biopharmaceutical company that provides an antibody engineering platform to design and develop precision radiopharmaceuticals for cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 1995 | Founding Date 2020 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Boulder, US Lexington, US | Locations Tampa, US HQ | Locations Menlo Park, US HQ Vancouver, CA |
Employees | Employees 1042% decrease | Employees 19 | Employees 723% increase |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 16m (about 8 years ago) | Latest funding round $ 110m (about 3 years ago) |
Total funding raised | Total funding raised $ 287.1m | Total funding raised $ 16m | Total funding raised $ 147.9m |
For sources of this data, please see the company profile
View Company Profiles
Morphogenesis
HQ
Tampa, US
Employees
19
Morphogenesis is a clinical stage company specializing in cell and gene therapies.
View companyAbdera Therapeutics
HQ
Menlo Park, US
Employees
72↑ 3% increase
Abdera Therapeutics is a biopharmaceutical company that provides an antibody engineering platform to design and develop precision radiopharmaceuticals for cancer.
View company